US-HEALTH-MODERNA

Sun hits the facade of the headquarters of biotechnology company Moderna in Cambridge, Massachusetts on November 16, 2020. - US biotech firm Moderna on November 16, 2020 announced its experimental vaccine against Covid-19 was almost 95 percent effective, marking a second major breakthrough in the quest to end the pandemic. Moderna released early results from a clinical trial with more than 30,000 participants, after American pharmaceutical company Pfizer and its German partner BioNTech last week said their vaccine was 90 percent effective. (Photo by MATTHEW HEALEY / AFP) (Photo by MATTHEW HEALEY/AFP via Getty Images)
Sun hits the facade of the headquarters of biotechnology company Moderna in Cambridge, Massachusetts on November 16, 2020. - US biotech firm Moderna on November 16, 2020 announced its experimental vaccine against Covid-19 was almost 95 percent effective, marking a second major breakthrough in the quest to end the pandemic. Moderna released early results from a clinical trial with more than 30,000 participants, after American pharmaceutical company Pfizer and its German partner BioNTech last week said their vaccine was 90 percent effective. (Photo by MATTHEW HEALEY / AFP) (Photo by MATTHEW HEALEY/AFP via Getty Images)
US-HEALTH-MODERNA
PURCHASE A LICENCE
How can I use this image?
$650.00
+GST AUD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
MATTHEW HEALEY / Contributor
Editorial #:
1229642761
Collection:
AFP
Date created:
16 November, 2020
Upload date:
Licence type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_8VB7U4
Max file size:
4000 x 2667 px (33.87 x 22.58 cm) - 300 dpi - 5 MB